Search Results
Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients
Comment: Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer pts
Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
HER2CLIMB and NALA Trials: R/R HER2+ mBC
Treatment strategies for HER2+ metastatic breast cancer
Therapeutic landscape for patients with HER2-positive breast cancer with active brain metastases
Metastatic HER2 Negative Breast Cancer: Emerging Novel Treatment Strategies
Trastuzumab deruxtecan doubles PFS in metastatic breast cancer with low HER2 expression
Management of HER2 positive metastatic breast cancer treatment algorithm
Advances in HER2-positive and HER2-low Breast Cancer